Menu Search
Equities

BBS-Bioactive Bone Substitutes Oyj

BONEH:HEX

BBS-Bioactive Bone Substitutes Oyj

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.308
  • Today's Change-0.002 / -0.65%
  • Shares traded66.80k
  • 1 Year change-41.62%
  • Beta0.1980
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in EURView more

In 2023, BBS-Bioactive Bone Substitutes Oyj increased its cash reserves by 29.93%, or 454.00k. Cash Flow from Financing totalled 3.38m or -- of revenues. In addition the company used 2.92m for operations while cash from investing was breakeven.
Cash flow per share-0.2702
Price/Cash flow per share--
Book value per share0.2647
Tangible book value per share-0.134
More ▼

Balance sheet in EURView more

BBS-Bioactive Bone Substitutes Oyj has a Debt to Total Capital ratio of 48.20%, a lower figure than the previous year's 106.27%.
Current ratio1.47
Quick ratio--
Total debt/total equity0.9305
Total debt/total capital0.482
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.